doi: 10.1016/S0140-6736(21)00388-3. Epub 2021 Feb 12.
Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission
Collaborators
- PMID: 33587888
- PMCID: PMC7906747
- DOI: 10.1016/S0140-6736(21)00388-3
Item in Clipboard
Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission
Lancet..
Erratum in
- Department of Error.Lancet. 2021 Mar 13;397(10278):970. doi: 10.1016/S0140-6736(21)00451-7.Lancet. 2021.PMID: 33714388Free PMC article.No abstract available.
No abstract available
Similar articles
- COVAX can still end COVID-19 vaccine apartheid.Nat Hum Behav. 2022 Feb;6(2):175. doi: 10.1038/s41562-022-01308-8.Nat Hum Behav. 2022.PMID: 35102357No abstract available.
- Looking beyond COVID-19 as a pandemic.Hong Kong Med J. 2021 Apr;27(2):88-89. doi: 10.12809/hkmj215114. Epub 2021 Apr 12.Hong Kong Med J. 2021.PMID: 33843608No abstract available.
- Uncertainties over EU COVID-19 vaccine sharing scheme.Lancet. 2021 Mar 27;397(10280):1171. doi: 10.1016/S0140-6736(21)00721-2.Lancet. 2021.PMID: 33773624Free PMC article.No abstract available.
- Vaccine hesitancy and COVID-19 vaccination in Hong Kong.Hong Kong Med J. 2021 Apr;27(2):90-91. doi: 10.12809/hkmj215115.Hong Kong Med J. 2021.PMID: 33879624No abstract available.
- Innovation alone won't end COVID-19.Nat Hum Behav. 2022 Feb;6(2):172-173. doi: 10.1038/s41562-022-01298-7.Nat Hum Behav. 2022.PMID: 35102360No abstract available.
Cited by
- COVID-19 vaccine decisions: considering the choices and opportunities.Microbes Infect. 2021 May-Jun;23(4-5):104811. doi: 10.1016/j.micinf.2021.104811. Epub 2021 Mar 17.Microbes Infect. 2021.PMID: 33744495Free PMC article.
- Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine.BMJ Glob Health. 2021 Jul;6(7):e006169. doi: 10.1136/bmjgh-2021-006169.BMJ Glob Health. 2021.PMID: 34253631Free PMC article.Review.
- Cold chain and severe acute respiratory syndrome coronavirus 2 transmission: a review for challenges and coping strategies.Med Rev (2021). 2022 Mar 1;2(1):50-65. doi: 10.1515/mr-2021-0019. eCollection 2022 Feb 1.Med Rev (2021). 2022.PMID: 35658108Free PMC article.Review.
- Linking healthcare and societal resilience during the Covid-19 pandemic.Saf Sci. 2021 Aug;140:105291. doi: 10.1016/j.ssci.2021.105291. Epub 2021 Apr 19.Saf Sci. 2021.PMID: 33897106Free PMC article.
- The Lancet Commission on lessons for the future from the COVID-19 pandemic.Lancet. 2022 Oct 8;400(10359):1224-1280. doi: 10.1016/S0140-6736(22)01585-9. Epub 2022 Sep 14.Lancet. 2022.PMID: 36115368Free PMC article.Review.No abstract available.
References
- WHO What is the ACT-Accelerator. 2020. https://www.who.int/initiatives/act-accelerator/about
- Ritchie H, Ortiz-Ospina E, Beltekian D, et al. Statistics and research: coronavirus pandemic (COVID-19). Our World in Data. 2021. https://ourworldindata.org/coronavirus
- Davies NG, Barnard RC, Jarvis CI, et al. Estimated transmissibility and severity of novel SARS-CoV-2 variant of concern 202012/01 in England. medRxiv. 2020 doi: 10.1101/2020.12.24.20248822. published online Dec 26. (preprint). - DOI
- Volz E, Mishra S, Chand M, et al. Transmission of SARS-CoV-2 lineage B.1.1.7 in England: insights from linking epidemiological and genetic data. medRxiv. 2021 doi: 10.1101/2020.12.30.20249034. published online Jan 4. (preprint). - DOI
- Mahase E. Covid-19: what have we learnt about the new variant in the UK? BMJ. 2020;371 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
